Singapore has a well-structured and rigorous regulatory framework for drug registration, which is overseen by the Health Sciences Authority (HSA) under the Health Products Act (HPA). The HSA is responsible for evaluating, approving, and regulating therapeutic products before they can be supplied... Read More
Japan has a well-defined regulatory framework for medical devices, ensuring their safety, efficacy, and quality before they reach the market. The process is governed by two key regulatory authorities: the Ministry of Health, Labour and Welfare (MHLW) and the Pharmaceuticals and Medical... Read More
The drug registration process in Korea is a meticulously structured system overseen by the Ministry of Food and Drug Safety (MFDS). This process is designed to ensure that all pharmaceuticals meet stringent standards of safety, efficacy, and quality before they are made... Read More
China’s pharmaceutical market, the second-largest globally, offers immense opportunities for international drug manufacturers. However, navigating the country’s drug registration process requires an in-depth understanding of its regulatory framework, primarily overseen by the National Medical Products Administration (NMPA). This article explores the critical... Read More
Introduction Korea’s medical device market is one of the fastest-growing in Asia, offering significant opportunities for international manufacturers. With a healthcare system that places a strong emphasis on cutting-edge medical technologies, entering the Korean market can be highly rewarding. However, to succeed,... Read More
Taiwan’s medical device registration system, managed by the Taiwan Food and Drug Administration (TFDA), is known for its well-defined regulatory framework and high standards for safety and efficacy. This process also encourages innovation, especially for digital and smart technology medical devices that... Read More
China’s pharmaceutical market, the second largest in the world, continues to attract international manufacturers of active pharmaceutical ingredients (APIs), excipients, and packaging materials. While the opportunities are vast, accessing this market requires a thorough understanding of China’s Drug Master File (DMF) registration... Read More
Introduction The field of companion diagnostics (CDx) is evolving rapidly in China, driven by advancements in precision medicine and targeted therapies. Companion diagnostics play a crucial role in identifying patient populations most likely to benefit from specific therapeutic agents, particularly in oncology.... Read More
Companion diagnostics (CDx) are essential tools in personalized medicine, ensuring that patients receive the most effective treatments based on their unique genetic and molecular profiles. These tests guide therapeutic decisions by identifying biomarkers, such as genetic mutations, that predict a patient’s response... Read More
Japan’s medical device market is one of the largest and most attractive in the world, offering immense opportunities for foreign companies. However, navigating this market comes with significant challenges that demand strategic planning and a deep understanding of the regulatory environment. This... Read More